Education
About Us
Working with TipRanks
Follow Us
Smith & Nephew Snats (SNN)
:SNN
SNN Stock Chart & Stats
$36.53
-$0.18(-0.73%)
At close: 4:00 PM EST
$36.53
-$0.18(-0.73%)
Day’s Range― - ―
52-Week Range$23.69 - $38.79
Previous CloseN/A
Volume262.39K
Average Volume (3M)482.36K
Market Cap
$14.03B
Enterprise Value$16.15B
Total Cash (Recent Filing)$675.41M
Total Debt (Recent Filing)$3.45B
Price to Earnings (P/E)29.0
Beta0.55
Next Earnings
Mar 02, 2026EPS Estimate
1.17Next Dividend Ex-DateN/A
Dividend Yield2.28%
Share Statistics
EPS (TTM)0.86
Shares Outstanding424,862,000
10 Day Avg. Volume593,629
30 Day Avg. Volume482,356
Financial Highlights & Ratios
PEG Ratio-1.21
Price to Book (P/B)2.05
Price to Sales (P/S)1.85
P/FCF Ratio17.78
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit3.86
Enterprise Value/Ebitda11.21
Forecast
1Y Price Target
$35.75Price Target Upside-2.14% Downside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)1.96
Revenue Forecast (FY)$6.14B
Bulls Say, Bears Say
Bulls Say
Innovation And Margin ExpansionSNN's innovation pipeline is promising, with initiatives expected to drive margin expansion and meaningful increases in ROIC.
Operational Savings And Profit MarginSmith & Nephew Snats reiterated its expectations to deliver 5% underlying growth and expects a stronger trading profit margin in the second half as it works to deliver on operational savings.
Strategic Structure And Financial ImprovementSNN transitioned to a simpler, business-unit led structure, increasing accountability and improving financial performance.
Bears Say
China Headwinds And Reimbursement ChangesChina headwinds and upcoming impacts from wound reimbursement changes are expected to continue affecting the company.
Market Challenges In US KneesSNN remains behind competitors in the US knees market, which continues to be a challenge.
Tariff ImpactsSNN continues to expect a $15–$20 million 2025 headwind due to potential US tariff impacts, with impacts compounding further in 2026.
Smith & Nephew Snats News
SNN FAQ
What was Smith & Nephew Snats’s price range in the past 12 months?
Smith & Nephew Snats lowest stock price was $23.69 and its highest was $38.79 in the past 12 months.
What is Smith & Nephew Snats’s market cap?
Smith & Nephew Snats’s market cap is $14.03B.
When is Smith & Nephew Snats’s upcoming earnings report date?
Smith & Nephew Snats’s upcoming earnings report date is Mar 02, 2026 which is in 69 days.
How were Smith & Nephew Snats’s earnings last quarter?
Smith & Nephew Snats released its earnings results on Aug 05, 2025. The company reported $0.858 earnings per share for the quarter, the consensus estimate of $0.858 by $0.
Is Smith & Nephew Snats overvalued?
According to Wall Street analysts Smith & Nephew Snats’s price is currently Overvalued.
Does Smith & Nephew Snats pay dividends?
Smith & Nephew Snats pays a Semiannually dividend of $0.285 which represents an annual dividend yield of 2.28%. See more information on Smith & Nephew Snats dividends here
What is Smith & Nephew Snats’s EPS estimate?
Smith & Nephew Snats’s EPS estimate is 1.17.
How many shares outstanding does Smith & Nephew Snats have?
Smith & Nephew Snats has 424,862,000 shares outstanding.
What happened to Smith & Nephew Snats’s price movement after its last earnings report?
Smith & Nephew Snats reported an EPS of $0.858 in its last earnings report, expectations of $0.858. Following the earnings report the stock price went up 15.221%.
Which hedge fund is a major shareholder of Smith & Nephew Snats?
Currently, no hedge funds are holding shares in SNN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Smith & Nephew Snats Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$35.75 (-2.14% Downside)
$35.75 (-2.14% Downside)
Blogger Sentiment
Bullish
SNN Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 309.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.56%
12-Months-Change
Fundamentals
Return on Equity
9.20%
Trailing 12-Months
Asset Growth
1.33%
Trailing 12-Months
Company Description
Smith & Nephew Snats
Smith & Nephew Snats (SNN) is a global medical technology company specializing in advanced wound management, orthopedic reconstruction, and sports medicine. The company operates in three main sectors: Advanced Wound Management, Orthopedics, and Sports Medicine. SNN offers a range of products including wound care dressings, surgical instruments, implants for hip and knee replacements, and minimally invasive surgical solutions for various orthopedic procedures.
SNN Company Deck
SNN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Smith & Nephew reported strong revenue growth, profitability improvements, and significant cash flow increases, along with a major share buyback announcement. However, challenges remain, particularly in emerging markets, and potential headwinds from U.S. tariffs and reimbursement changes. Overall, the company appears optimistic about sustaining growth and improving margins.View all SNN earnings summariesSNN Stock 12 Month Forecast
Average Price Target
$35.75
▼(-2.14% Downside)
Technical Analysis
Boston Scientific
―
Edwards Lifesciences
―
Medtronic
―
Stryker
―
Zimmer Biomet Holdings
―
Ownership Overview
―
Insiders
0.37% Mutual Funds
2.95% Other Institutional Investors
96.46% Public Companies and
Individual Investors